NCT02711384View on ClinicalTrials.gov

MACBIS50 in Patients Undergoing CAG During Normothermic CPB Phase.

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 25, 2018

Primary Completion Date

February 25, 2020

Study Completion Date

February 28, 2020

Conditions
Coronary DiseaseCoronary Artery Disease
Trial Locations (1)

04012-909

Instituto Dante Pazzanese de Cardiologia, São Paulo

All Listed Sponsors
lead

Instituto Dante Pazzanese de Cardiologia

OTHER

NCT02711384 - MACBIS50 in Patients Undergoing CAG During Normothermic CPB Phase. | Biotech Hunter | Biotech Hunter